Sector
1090 stories · page 46 of 55
"In working with Sport-Orthèse, we're signalling our dedication to our European clientele and furthering our goal for continued success on the continent," said Adam Cegielski, Binovi founder and CEO
The acquisition expands Numinus' presence into Quebec, building on its Vancouver office with two established locations and extensive virtual services as well as insights garnered from a decade of successful clinic management.
He will lead the R&D initiatives of N,N-Dimethyltryptamine (DMT) for mental health, neurological, and inflammatory disorders
Not just that, the Canada-listed business has planted flags in Germany and the Netherlands
Chairman Roger McIntyre said vice-chair Bill Wilkerson has retired from the board while former senior television executive Olga Cwiek will be joining
The six-item patient-administered RMS differentiates the more cyclical bipolar I disorder compared to MDD in patients with depressive symptoms
The new Canadian Rapid Treatment Centre of Excellence (CRTCE) provides ketamine treatment for adults with depression
The certification proves that the company’s nitrile gloves conform to EU health and safety standards and would allow its products to command higher selling prices.
The Toronto-based firm raised a combined $3.1 million during its third-quarter through private placements with strategic investors
Though it was smashed in mid-March, the ASX healthcare sector recovered and held up better than most of the market, according to experts.
FLEX 10 is ImmunoFlex's unique N-Acetyl-L-cysteine formulation in packs of 30-600 mg capsules
The two companies are leading distributors of dental products in the US
Champignon Brands CEO Dr Roger McIntyre has authored an article in The Lancet which provides an overview of bipolar disorders and treatment, while highlighting relevant clinical controversies
He will assist in the expansion and analysis of clinical data on the ongoing US FDA Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate coronavirus
Feedback from end-users and resellers is that initial orders will occur immediately upon Mernova’s launch into hash.
The Toronto-based firm is the first publicly traded company that has a legal psilocybin product on store shelves and online
Patrick Kroupa will join the biotech as Chief Psychedelics Officer, while Justin Kirkland will be the group's Chief Psychedelics Scientist
Taat is focused on hemp-based products with its Beyond Tobacco cigarettes that do not contain tobacco or nicotine
The trials will evaluate REQORSA in combination with AstraZeneca’s drug Tagrisso and Merck & Co’s Keytruda
He is board-certified in vision therapy as a Fellow in the College of Optometrists in Vision Development (COVD), and is a Fellow in the American Academy of Optometry (AAO)
